Cross talk between cellular regulatory networks mediated by shared proteins. by Dolde, Christine et al.
Review Article
Cross Talk between Cellular Regulatory Networks Mediated by
Shared Proteins
Christine Dolde, Jiongming Lu, and Beat Suter
Institute of Cell Biology, University of Bern, Baltzerstraße 4, 3012 Bern, Switzerland
Correspondence should be addressed to Beat Suter; beat.suter@izb.unibe.ch
Received 4 March 2014; Accepted 2 June 2014; Published 25 June 2014
Academic Editor: Qianzheng Zhu
Copyright © 2014 Christine Dolde et al.This is an open access article distributed under theCreative CommonsAttribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Moonlighting proteins mediate cross talk between different pathways and cellular control networks. Sometimes, they even
coordinate subsequent steps in the same pathway. For this Outlook paper we asked the question, which cellular processes employ
multifunctional proteins (MFPs) and what makes them so attractive to cells and organisms. After reviewing their widespread
occurrence, we will focus on higher eukaryotic model systems and on few examples that are linked to ongoing work in our
laboratory. We will discuss the activities of transcription factor IIH (TFIIH), and its subcomplexes containing Xpd and Cdk7, and
we will cover an aminoacyl-tRNA synthetase (LysRS) and DEAD box RNA helicases. Furthermore, we will analyze how cells are
able to properly regulate the different biological activities of multifunctional proteins and which advantages such proteins offer to
cells and organisms. Finally we also note that the proteins we discuss are linked to tumor formation or recruited by viruses that
coopt the multifunctional protein for yet another purpose.
1. Introduction
For decades one hypothesis ruled most scientist’s mind: one
gene gives rise to one protein, which performs one specific
role in the cell. Nowadays, this hypothesis gets severely
challenged as there is increasing evidence that many proteins
perform multiple functions and many cells seem to exploit
the opportunities offered by these multitask proteins.
Numerous cellular control processes act simultaneously
in the same cell and many proteins function in more than
one control process. This realization has spurred our interest
in finding out how cells take advantage of such dual- or even
multifunctional proteins (MFPs). There are examples of dual
roles that appear to be simple evolutionary “duplication steps”
(Figure 1). Such MFPs can then be found in different pro-
tein complexes, which account for their different biological
functions. In other cases, however, MFPs regulate parallel
or subsequent cellular processes in a coordinated fashion
(Figure 2). This points to a higher level of cellular control
associatedwith the reuse of this protein. In yet other cases two
alternative pathways share a component that is present only
in limited amounts in the cell and this low abundance allows
it to only function in one process at the time (Figure 3). In
this case cells may use such a protein as a switch between two
alternative processes, regulating them in an inverse manner.
In this outlook paper we briefly document how
widespread MFPs are by covering some examples from
single cell model systems. We will then focus on studies
that used multicellular organisms and on aspects related to
our own research. Using these examples we will provide a
more in depth analysis of the roles of MFPs and on how cells
and multicellular organisms take advantage of the multiple
activities of these proteins.
Evolutionary Duplication Steps. Research with microorgan-
isms has a long tradition of pioneering cellular control
processes. With regard to MFPs, a recent publication nicely
illustrates howMFPs are identified and shown to be function-
ally important [1].The ubiquitin pathway targets intracellular
proteins for degradation by the proteasome, a multiprotein
complex that consists of over 30 subunits. Interestingly, the
lid of the proteasome is an eight-subunit complex that bears
homologies to COP9 signalosomes (CSN), a metalloprotease
that consists of several subunits and regulates the activity of
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Figure 1: Evolutionary duplication steps. MFPs can be found in
different complexes, promoting different activities. For example,
RPN5 is a component of the CSN and the lid of the proteasome.
a family of E3 ubiquitin ligases. By comparing the proteasome
lid to the CSN complex, the authors identified RPN5 (regu-
latory particle non-ATPase) as a common protein. Because
RPN5 mutants show phenotypes indicative of proteasome
and CSN defects, it seems that RPN5 plays critical functions
as part of the CSN in addition to its essential roles in the
proteasome. Rpn5 is required in the proteasome complex for
proteolysis and in the CSN complex for cullin-derubylation
(removal of Rub1/Nedd8). While this presently looks like
a simple case of reusing a component that is associated
with different activities (Figure 1), further work needs to test
whether the organism takes advantage of this dual use.
Alternative Regulation of Different Cellular Processes. Bac-
terial survival depends mainly on sensing environmental
changes. Helpful players are intracellular stress alarmones
like guanosine tetraphosphate and guanosine pentaphos-
phate, (p)ppGpp, originally described as the “magic spot” [2,
3].They regulate the stringent response that consists of global
gene regulatory changes leading to reduced metabolism and
growth inhibition. Once conditions become more favorable
again for bacterial growth, (p)ppGpp levels are downreg-
ulated and bacterial cells resume their biosynthetic activ-
ities and growth. In Gram-positive bacteria, production
and hydrolysis of (p)ppGpp are regulated by the same
bifunctional enzyme, Rel (Msm), which consists of a single
polypeptide that is able to perform (p)ppGpp synthesis
through its SYNTHdomain and hydrolysis through a domain
present at the C terminus [4]. Interestingly, uncharged tRNA
seems to regulate the activity of Rel (Msm). tRNA is able
to bind to Rel and this induces a conformational change
that favors (p)ppGpp synthesis. In this case, a mechanism
of alternative or inverse regulation has evolved in which
the presence of the two domains with inverse activity in a
single polypeptide chain allows alternative activation of one
of the two activities and inactivation of the second, thereby
preventing futile cycles of (p)ppGpp synthesis and hydrolysis
[5–7] (Figure 3(a)).
Coordinated Regulation of Successive Steps in the Same Bio-
logical Process. MFPs can also serve to coordinate successive
cellular processes (Figure 2(a)). For instance, when cells
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Figure 2: MFPs are involved in successive or parallel processes.
If the amount of MFPs is not limited in the cell, they can be
involved in multiple subsequent steps within one biological cascade
(a). An example for this is Pex3p. In addition MFPs can promote
two pathways simultaneously (b). As discussed in the text, the two
parallel pathways may later converge onto a common purpose like
promoting cell proliferation (this can be the case for Cdk7).
MFP MFP
(a)
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(b)
Figure 3: MFPs act as molecular switches by regulating alternative
activities. If MFPs are limited in the cell, they only promote one
pathway. There are cases where the same enzyme is able to promote
or repress a specific path (a) and Rel (Msm) illustrates this example
in the text. In other cases the MFP has the capacity to activate two
alternative pathways and, if limited in its amount, it will activate
one at the expense of another. In particular in the cases discussed
here the proper regulation of the MFP activity is crucial. Discussed
examples for this are the role of Xpd in steering the CAK activity and
also LysRS.
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divide, they need to distribute their organelles to both
daughter cells. The peroxisome is such a cellular organelle
and in Saccharomyces cerevisiae PEX3 is one of the genes
required first for peroxisome biogenesis and then for proper
distribution of peroxisomes during cell division [8]. Pro-
moting peroxisome biosynthesis, Pex3p first appears in the
endoplasmic reticulum (ER). Subsequently it associates with
a peripheral peroxisomal membrane protein Inp1p to anchor
the peroxisome at the cell periphery [9]. Lack of Pex3p
or mutations that prevent interaction with Inp1p result in
a peroxisome retention defect and most peroxisomes are
transported into the daughter cell [10].
2. Activities of XPD and Cdk7 in and
out of TFIIH
An amazing variety of functions have been associated with
the general transcription factor IIH (TFIIH) and, accordingly,
the variety of differential regulation controlling these func-
tions is impressive. We got interested in these processes by
studying two TFIIH components, Cdk7 (cyclin-dependent
kinase 7) and XPD (xeroderma pigmentosum D). Metazoan
XPD is also called ERCC2 and functions in transcription,
nucleotide excision repair (NER), cell cycle control, and even
organization of themitotic spindle and chromosome segrega-
tion [11–16]. XPD is a DNA helicase and its helicase activity is
necessary for its NER function.On the other hand, XPDplays
only a structural role in transcription, where it helps forming
a stable TFIIH complex, and it acts as a molecular dispatcher
for the Cdk-activating kinase complex CAK in its cell cycle
function [16–19]. The XPD polypeptide can be isolated from
several different complexes, including the TFIIH complex.
TFIIH contains 9 additional polypeptides, p34, p44, p52, p62,
XPB, TFB5 (also called TTD-A and p8), Cdk7, Cyclin H,
and Mat1 [20–22]. This complex is also found split into two
subcomplexes, the CAK subcomplex, consisting of the last
three subunits (Cdk7, cyclinH, andMat1), and the core TFIIH
with the other subunits. XPD itself can associate with both
of these two subcomplexes, even though CAK is often found
only as a trimer. Another XPD complex has been identified
in mammalian cells. In this complex XPD is the only TFIIH
subunit found in the complex and it associates with MMS19
and MIP18, which led to the complex name MMXD [14].
TFIIH and its subcomplexes are involved in the regula-
tion of transcription, DNA repair, cell cycle progression, and
chromosome segregation [11–15, 17]. This amazing number
of different cellular complexes and processes, some of which
are mutually exclusive, while others happen concurrently,
captured our attention. The interplay between the different
complexes and functions is only partially understood, and
there does not seem to exist a single unifying mode of
regulation. However, one important mode of regulating the
different activities of XPD and the Cdk7 kinase is through
forming complexes of different composition. The different
TFIIH complexes and subcomplexes perform at least some of
their different in vivo functions through structurally different
complexes.The trimeric CAK (Cdk7/CyclinH/Mat1) exhibits
a strong substrate preference for the cell cycle targets, the
Cdks, and is less active against the C-terminal domain (CTD)
of RNA Polymerase II (PolII) and CTD peptides, whereas
TFIIH-associated CAK preferentially phosphorylates the
CTD [23–28].
2.1. Transcription and Cell Cycle Functions. The dual-use
subunit CAK with the Cdk7 kinase allows the cell to prepare
in a coordinated way for growth and proliferation activity.
It does this by regulating the availability and activity of the
CAKcomplex. IncreasingCAK, for instance, through subunit
synthesis, stabilization, or modification, would promote both
pathways. It would stimulate transcription by providing
ample TFIIH complexes and it would activate cell cycle
Cdks by providing an excess of free CAK (Figure 2(b)). This
mechanism seems to be at work in tumor cells because it
was found that many tumors express elevated levels of Cdk7
compared to the corresponding normal cells [29]. In contrast
to the simultaneous regulation and on a different time scale,
cells can take advantage of the same duality of complexes
and functions in a different way. As cells enter mitosis, they
shut down transcription and simultaneously upregulate Cdk1
activity through different mechanisms [19, 30].
In this situation Drosophila XPD plays a decisive role
during the embryonic division cycles. It regulates whether
the trimeric CAK complex is associated with TFIIH, which
promotes transcription activation by phosphorylating the
CTD of PolII, or whether CAK is free and activates the cell
cycle Cdks by phosphorylating their T-loop [13, 30]. If in this
situation XPD is the limiting factor in the cell, its removal
from TFIIH simultaneously shuts down the transcription
activity of TFIIH and releases free CAK to perform its
Cdk1 T-loop phosphorylation function that activates the
M-phase kinase. This dual-use of CAK corresponds to the
alternative activity mode as depicted in Figure 3(b). As long
as sufficient amounts of XPD are present, CAK is used in the
protein complex TFIIH, leading to transcription promotion.
Reducing the availability of XPD sets free the CAK complex
to promote activation of cell cycle Cdks.
2.2. Transcription and DNA Repair. During PolII transcrip-
tion, TFIIH associates with other TFIIs and with PolII, and
it phosphorylates the CTD of PolII and TFIIE (reviewed in
[31–33]). For its DNA repair function during NER TFIIH
is recruited to the damage site by associating with repair-
specific factors (CSA, CSB, or XPC/hHR23, reviewed by
[34]). At this point, significant activity changes happen.
TTDA is the tenth TFIIH subunit and it specifically functions
in DNA repair. The interaction of TTDA with the TFIIH
core components p52 and XPB stimulates the ATPase activity
of XPB, anchoring TFIIH to the damaged DNA [20, 35–38]
reviewed in [16]. Once bound, the interaction between the
other TFIIH components p34, p44, and XPD stimulates the
XPD helicase activity [39, 40]. Furthermore, the association
with yet another NER component, XPA, causes CAK to
disassociate from the core TFIIH [41] and the helicase activity
of the TFIIH-bound XPD now locally unwinds the DNA
and maybe also remodels PolII, giving the NER machinery
access to the lesion [18, 42]. Differential complex formation
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therefore decides whether TFIIH is active as transcription
factor or in NER (Figure 3(b)).
2.3. Other Complexes and Functions. As the picture of these
interwoven control mechanisms starts to take shape, novel
pathways are still discovered. The role of the recently discov-
ered MMXD complex in the control of XPD activity, chro-
matin segregation, and spindle organization is not clear yet
[14]. While it was proposed that this XPD complex plays an
active role in mitosis, the function of MMXD may also be to
sequester XPD at the timewhen highCAKactivity is required
and TFIIH-dependent transcription becomes silenced. On
the other hand, the finding thatMMS19 is part of the cytosolic
iron-sulfur (FeS, Fe/S) cluster assemblymachinery (CIA) [43,
44] may also point to a more trivial involvement of MMS19
in supplying functional and stable XPD. The accumulation
of this complex in mitosis may then simply reflect stalled
assembly of functional XPD. Clearly, more work is needed to
understand this part of the XPD network and its implication
for controlling the various activities of XPD, Cdk7, and
TFIIH.
3. Lysyl-tRNA Synthetase: Multiple Functions
in and Beyond Aminoacylation
Lysyl-tRNA synthetase (LysRS) is a highly conserved enzyme
involved in protein translation. It catalyzes the ligation of
the amino acid lysine to its cognate tRNA, a process called
aminoacylation [45]. The structure of LysRS has been solved
and this provided many new insights into its function
[46, 47]. In its C-terminal aminoacylation domain, human
LysRS contains the three consensus sequences (motif 1, 2,
and 3) that are common to all class II aminoacyl-tRNA
synthetases (aaRSs). In the N-terminal part, it is composed
of the anticodon binding domain and an extra eukaryotic
extension. The functional enzyme for aminoacylation is a
homodimer, in which two molecules form in a symmetric
way through the interface that involves the consensus motif
1 [47]. This canonical aminoacylation function of LysRS is
essential for the development, survival, and reproduction of
each cell, tissue, and organism [48, 49].
In higher eukaryotes LysRS forms several complexes,
which link it to diverse biological processes [50, 51]. Together
with other aaRSs, LysRS can form a large complex, known
as multisynthetase complex (MSC), which is composed of at
least eight aaRSs and the three auxiliary factors AIMP1 (also
known as p43), AIMP2 (also known as p38), andAIMP3 (also
known as p18) [52–54]. In this complex LysRS dimers interact
with the N-terminus of AIMP2 to form the LysRS/AIMP2
subcomplex [55, 56]. The binding of LysRS to AIMP2 does
not induce a conformational change and, because of this,
the aminoacylation activity of LysRS remains similar when
bound to the MSC [47, 57].
The exact function of the MSC is not clear, but it is
thought to serve as a reservoir for cellular tRNA synthetases
and to regulate their functions beyond aminoacylation [58,
59]. Due to its involvement in different signaling pathways,
the MSC was described as “signalosome” [60]. Interestingly,
the majority of LysRS in quiescent cells is associated with the
MSC where it keeps its dimeric structure, and only a small
fraction is present in the free form [61]. How this balance is
controlled is still unclear. However, it seems that both forms
are synchronously involved in protein translation. The MSC
was shown to be essential for normal protein synthesis and for
growth of mammalian cells, and it was also reported that the
MSC per se is required for normal development in the mouse
[62–64]. It therefore appears that the two different LysRS
complexes may take on different functions in translation.
3.1. LysRS in Regulation of Transcription. LysRS is known
to be the major contributor to the synthesis of Ap
4
A in
mammals [65, 66]. Ap
4
A, a diadenosine polyphosphate, is
composed of two adenosines linked in a 5󸀠-5󸀠 manner by a
chain of four phosphates. This molecule is highly charged
and can bind to proteins. In mast cells, the microphthalmia
transcription factor (MITF) plays important roles in allergic
reactions. Its transcription activity is repressed by its interac-
tionwith the repressor proteinHint-1 in quiescent cells. Upon
antigen-lgE induced activation of mast cells, the binding of
Ap
4
A to Hint-1 releases Hint-1 from MITF and therefore
activates transcription from its target genes [67]. LysRS
is crucial for this signaling and knocking down of LysRS
abrogates the immune induction through Ap
4
A, resulting in
low levels of MITF-target genes. It was demonstrated that
LysRS forms a complex with MITF and Hint-1, leading to
the local accumulation of Ap
4
A [68]. Besides MITF, another
ubiquitously expressed transcription factor, USF2, is also
regulated by LysRS in this way [69].
LysRS is a cytoplasmic protein, and the transcription
regulation occurs in the nucleus. The obvious question is
therefore how LysRS translocates into the nucleus and from
which pool this LysRS originates from. Recent studies showed
that upon immunological challenge, LysRS is phosphorylated
on Ser207, released from the MSC, and it translocates to
the nucleus. The phosphorylation is carried out in a MAPK-
dependentmanner, since a preincubation of cells withMAPK
inhibitors prevented the phosphorylation, dissociation, and
translocation of LysRS [61]. Also, the observation that the
phosphomimetic mutant LysRSS207D localizes constitutively
to the nucleus, even in quiescent cells, indicates that the phos-
phorylation itself may be able to induce nuclear translocation
[70].
A study published recently clarified in detail how LysRS
switches functions from translation to transcription [70].
Phosphorylation of Ser207 triggers a conformational change
of LysRS that opens its N-terminal tRNA anticodon-binding
domain. This open conformation of LysRS disrupts its inter-
action with AIMP2, inducing its release from theMSC. In the
nucleus, the Ser207 phosphorylation of LysRS is also crucial
for Ap
4
A synthesis. A first step leads to the generation of
Lysyl-AMP, analogous to its activity in aminoacylation. In the
second step, Lysyl-AMP interacts with a second ATP to form
the Ap
4
A, and a Lys is released. The Ser207 phosphorylated
LysRS with its open N-terminal domain, specifically turns
off the second step of aminoacylation and promotes Ap
4
A
synthesis, thus switching its function from translation to
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transcription. The switch to the transcriptional function has
the potential to simultaneously interfere with translation if
the amount of LysRS is limited (Figure 3(b)). Whether this
is the case and whether the switch indeed affects translation
in vivo still needs to be tested.
3.2. LysRS in HIV Infection. During HIV-1 infection, the
human cytoplasmic isoacceptors, tRNALys1, tRNALys2, and
tRNALys3 are selectively packaged into the virus and tRNALys3
serves as the primer for reverse transcription of the viral
RNA. The incorporation of tRNALys into HIV-1 seems to be
mediated by its binding to LysRS, which can further interact
with the viral precursor protein Gag and also be packaged
into the virus [71–73]. The interaction between LysRS and
Gag was mapped to the consensus motif 1 of LysRS and the
C-terminal domain (CTD) of the capsid, a mature protein
processed from Gag [74, 75]. Additional presence of the viral
precursor protein Gag-Pol, which interacts with tRNALys as
well, is also needed for tRNALys packaging and might be able
to stabilize the Gag/LysRS/tRNALys complex [76, 77]. In this
way, LysRS plays an important role in the HIV-1 infection
cycle.
Based on several observations it is clear that the role of
LysRS in HIV-1 infection is not dependent on its aminoa-
cylation activity. First, C-terminally truncated LysRS, which
is able to bind to tRNALys, but cannot aminoacylate it, still
packages tRNALys into virions [78]. Second, as mentioned
above, the interaction between Gag and LysRS was mapped
to the consensus motif 1, which overlaps with the core
dimerization domain, indicating that LysRS interacts with
Gag as a monomer, which is inactive in aminoacylation. And
finally, a recent study demonstrated that monomeric LysRS
binds to Gag and tRNALys [75]. Although its aminoacylation
activity is not necessary, the ability of LysRS to bind to
tRNALys is required for packaging. The source of LysRS that
gets recruited for virion packaging remains to be determined.
It is not known yet whether it originates from the free LysRS
pool or is released from the MSC.
During HIV-1 amplification, the cellular dimeric LysRS
converts to a monomer that switches off or loses the aminoa-
cylation activity, forms the Gag/LysRS/tRNALys complex and
is packaged as such into virions. Because these processes are
sensitive to alterations of LysRS level [79], it appears that
LysRS is limiting. As a consequence, the recruitment of LysRS
into the virus acts as a functional switch from translation to
virion assembly (Figure 3(b)).
In summary, LysRS is an ancient enzyme that performs
multiple functions and at least two different mechanisms act
on LysRS to regulate it by turning a functional switch. Com-
petition for protein interactions through a single domain and
phosphorylation induced conformational changes control its
involvement in different pathways. Adding to the palette of
LysRS functions, it was recently shown that LysRS can also
be secreted as a cytokine-like molecule from certain cancer
cell lines and that it is also involved in cancer cell migration
[80, 81]. Due to its diverse functions, the malfunctioning
of LysRS facilitates many types of diseases, including HIV
infection, cancers, immunological diseases, and also neu-
rodegenerative diseases [51]. Therefore, LysRS serves as an
interesting example to demonstrate how one protein forms
different complexes and plays roles in different multicellular
processes in physiological and pathological conditions.
4. Multiple Functions of DEAD Box
RNA Helicases
DEAD box RNA helicases are multifunctional proteins in
the context of RNA linked processes [82]. These ancient
and highly conserved RNA helicases, characterized by their
shared motif Asp-Glu-Ala-Asp (DEAD), can be found in
all three kingdoms of life and have been studied in several
eukaryotic and prokaryotic systems [83].The first discovered
DEAD box RNA helicase was the eukaryotic translation ini-
tiation factor 4A (eIF4A). It was initially described together
with other translation initiation factors to recruit the small
ribosomal subunit to the 5󸀠 cap structure of RNA. Later, it was
shown that eIF4A contains an RNA induced ATPase activity
which results in local unwinding of RNA strands (reviewed
in [84]).
In general, DEAD box RNA helicases use ATP to bind or
remodel RNA or RNA-protein complexes [85]. It is notewor-
thy, that many DEAD box helicases have no enzymatic activ-
ity despite their sequence similarity. Instead, they function as
anchors for protein complexes, as RNP (ribonucleoprotein)
remodeling enzymes, as catalysts for RNA folding, and as
RNA transporters (reviewed in [86]). Just recently, DEAD
box proteins were discovered to function in cell-to-cell
communication independent of their previously described
RNA-associated functions [87, 88]. This outlook focuses on
DEAD box RNA helicases 3 and 5 (DDX3 and DDX5/p68,
resp.) and their various biological functions within several
protein complexes.
4.1. RNA-Linked Processes Involving DDX3 and DDX5/p68.
Both RNA helicases are members of the DEAD box RNA
helicase family with demonstrated RNA helicase activity [89,
90]. The possible mechanism by which DEAD box RNA
helicases denature double strand RNA has been elucidated
with yet another DEAD box protein, Vasa. In the presence
of ATP, the substrate RNA, in this case a single strand
RNA (ssRNA), is bent by an alpha helix typical for the N-
terminal domain of DEAD-box proteins [91]. It has been
suggested that this “kinked” RNA structure is only possible
with ssRNA and not for dsRNA. The authors speculate that
due to the structural information dsRNA can be locally
denatured, which leads to the unwinding of short dsRNA or
secondary structures in ssRNA.
DDX3 and DDX5/p68 are both required for several steps
during gene expression. DDX3 is involved in transcription,
RNA maturation, RNA export, mRNA translation, and even
RNA storage (reviewed in [82]). DDX5/p68 is involved in
transcription, RNA maturation and RNA decay (reviewed
in [92]). Their multifunctionality within one pathway is
another example of how proteins are used for the successive
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coordination of cellular processes (see Figure 2(a)). Interest-
ingly, the transcriptional function of DDX3 takes place at
the promoter, whereas DDX5/p68 interacts with transcrip-
tion factors and affects transcription indirectly. Chromatin-
immunoprecipitation experiments revealed that DDX3 binds
to the promoter region of E-cadherin and IFN𝛽. Surprisingly,
DDX3 upregulates the expression of IFN𝛽, but downregulates
the E-cadherin expression [93–95]. How DDX3 targets spe-
cific promoter regions, whether it gets recruited to these sites
by transcription factors, and why it can have different effects
on different promoters remain to be determined. DDX5/p68
can also play a positive or a negative role in transcription
independent of its helicase activity (reviewed in [92]). It acts
as a cofactor for transcription factors including the nuclear
hormone receptor estrogen receptor alpha (ER𝛼) [96] and
as a corepressor by interacting with histone deacetylase 1
(HDAC1), a well-established transcriptional repressor pro-
tein [97].
The involvement of DDX at the next level of gene
expression was revealed by studies performed in yeast. The
DDX3 homolog Ded1p interacts with the spliceosome and is
involved in RNAmaturation [98]. A genomewidemicroarray
analysis corroborated its function in mRNA splicing [99].
DDX5/p68 is involved in pre-mRNA splicing, alternative
splicing, rRNA processing, andmiRNAprocessing (reviewed
in [92]). The next step of gene expression involving DDX3
and DDX5/p68 is the nuclear export of RNA. One intriguing
observation was that several viruses coopt this particular
function of DDX3 and DDX5/p68 to export their viral RNA
from the nucleus to the cytoplasm [100–103].
Several groups implicated DDX3 in mRNA translation
once the mRNAs arrive in the cytoplasm [104, 105]. Yeast
Ded1p is required together with other translation initia-
tion factors (e.g., eIF4e, eIF4a, eIF2𝛼, PABP, and eIF3)
for unwinding 5󸀠 untranslated regions (UTRs) to facilitate
protein synthesis (reviewed in [106]). While the involvement
of DDX3 in translation has been demonstrated, this function
does not seem to affect mRNAs globally but seems rather
restricted to the translation of specific mRNAs. At the
end of the expression of an mRNA, DDX3, together with
other RNA helicases like DDX5/p68, finally plays a role
in RNA storage and clearance [107–110]. The involvement
of DDX3 and DDX5/p68 during gene expression reflects
the multifunctionality of one single protein, which displays
its functions at different epistatic levels within the same
pathway, gene expression. In most cases DDX helicases seem
to promote gene expression at different levels, teaming up
with different protein complexes (Figure 2(a)).
4.2. DDX3 and DDX5 in Cell-to-Cell Communication.
Despite decades of studies of their RNA-associated functions,
only recently DDX3 and DDX5/p68 were associated
with the prominent Wnt/𝛽-catenin signaling pathway
[87, 88]. This signaling pathway controls complex cell
behaviors throughout embryonic development, including
cell proliferation, stem cell maintenance, and cell fate
decisions. In 2006, Yang et al. [87] provided the first evidence
that a DEAD box RNA helicase plays a role in Wnt signaling.
DDX5/p68 acts within this signaling cascade as an activator
independently of the ligand Wnt itself [87]. DDX5/p68
becomes stimulated via phosphorylation by platelet-derived
growth factors (PDGF). It displaces the inhibitor protein
axin from 𝛽-catenin, blocks the phosphorylation of 𝛽-
catenin, which would otherwise lead to the proteasomal
degradation of the latter, and enables 𝛽-catenin to shuttle
into the nucleus in order to promote transcription of Wnt
target genes. Therefore, DDX5/p68 is not required for
Wnt signaling, but it modulates the pathway and links
it to PDGF signaling. In contrast, DDX3 is required for
Wnt signaling [88]. It binds to the casein kinase 1 isoform
epsilon (CK1𝜀) and stimulates the velocity of the kinase.
This results in the Wnt-dependent phosphorylation of the
signal transducing protein Dishevelled and leads to the
𝛽-catenin dependent transcription of Wnt target genes.
Interestingly, the interaction of endogenous DDX3 and
CK1𝜀 is insensitive to RNase treatment, corroborating that
this novel biological function cannot be linked to its RNA
binding ability. Concluding from this study, only the protein
structure of DDX3 is required for Wnt/𝛽-catenin signaling,
while the enzymatic activity of the helicase is dispensable
[88].
4.3. Modifications of DDX Proteins Seem to Discriminate
between Their Different Biological Functions. The multifunc-
tionality of DEAD box RNA helicases led to the question of
how these different functions are called upon and executed.
For DDX3 it is not known yet, whether it still performs
its role in RNA-associated processes when it is active in
Wnt signaling. We also do not know yet what might trigger
these different biological functions. Notably, the enzymatic
activity of DDX3 is dispensable for its function in cell-to-cell
communication. This is an interesting parallel to the DNA
helicase XPD, which requires its enzymatic activity for NER,
but only its structural function for transcription.
Regarding DDX5/p68, Yang and coworkers [87] tested
whether the ATPase and helicase activity was necessary
for DDX5/p68’s “Axin-displacement activity” by introducing
point mutations in the C-terminal helicase region. Because
these mutations affected both activities, it appears that
ATPase and helicase activities may be required for axin-
displacement. However, it cannot be ruled out that the
mutations affected the structure of the whole C-terminal
helicase domain. In the case of DDX3, the ATPase activity
is clearly not required for its function in Wnt signaling
because deletion of the N-terminal helicase region abolishes
the ATPase activity but leaves Wnt signaling intact.
How are these two DEAD box RNA helicases regulated
to function on one hand during gene expression [105, 111,
112] and on the other hand in cell-to-cell communica-
tion [87, 88]. One hint comes from the observation that
DDX5/p68 contains many posttranslational modifications. It
is phosphorylated, acetylated, and sumoylated [92, 113, 114].
These modifications affect its interaction with other proteins
and thereby steer its activity towards different biological
processes. DDX5/p68 becomes phosphorylated in response
to PDGF stimulation [87] and the responsible kinase may
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Figure 4: Possible mechanisms of MFP regulation. MFPs perform their function in the cell either by applying their enzymatic activity or
simply through their structural function, for instance, as scaffold proteins (a). Furthermore, MFPs often associate with alternative proteins,
which trap them in individual protein complexes to perform specific roles (b). Finally, MFPs can be regulated by modifications or molecular
interactions that affect their conformation. Conformational changes may block one of their activity (e.g., the enzymatic activity) or block the
formation of one of the complexes. In this way the conformational change may promote one of the pathways over the other (c).
be p38 MAP kinase. The MAP kinase phosphorylation
target site on DDX5/p68 is crucial for its function in
facilitating nuclear translocation of 𝛽-catenin [114]. Further
studies showed that phosphorylation of tyrosines in the C-
terminal domain of DDX5/p68 abolish its RNA unwinding
activity [114]. Therefore, there are clear indications that the
different modifications of DDX5/p68 regulate its biological
activity. The combined effects of phosphorylation of the C-
terminal helicase domain by p38 MAP kinase and a tyrosine
kinase resemble molecular switches directing the different
DDX5/p68 functions.
Interestingly, DDX3 is also phosphorylated by CK1𝜀 in
vitro. However, further work needs to clarify whether this
phosphorylation is relevant for DDX3 function in vivo and
whether this affects its RNA helicase activity. An interesting
observation was made by discovering that both DEAD box
RNA helicases, DDX3 and DDX5/p68, are able to interact
with each other [115]. They seem to interact throughout the
cell cycle, however, with changing affinities. The dynamics of
their interactions was linked to the phosphoisoform pattern,
which seems to change for both DEAD box proteins over the
cell cycle [115]. It appears that these phosphorylation events
could be relevant to control points because phosphatase
treatment of both RNA helicases led to an enhancement
of their interaction. Remarkably, during G2/M phase, when
Wnt/𝛽-catenin signaling is highly active [116], serine phos-
phorylation levels of DDX3 are low [115], suggesting that
the CK1𝜀 binding to DDX3, which happens primarily during
active Wnt signaling [88], prevents S/T phosphorylation of
DDX3. However, further experiments are needed to shed
more light on how DEAD box RNA helicases switch between
RNA-associated mechanisms and protein-protein interac-
tions wherein ATP hydrolysis is mostly not required.
When considering the different functions of DEAD box
RNAhelicases, an evolutionary considerationmay shed some
light on how this type of molecule was able to assume such
different molecular activities and functions. DEAD box RNA
helicases are present in all metazoans as well as in single-
cell organisms like yeast and even in prokaryotes like E.
coli and Staphylococcus. However, cell-to-cell communication
like Wnt signaling does not occur in single-celled organisms
[117–119]. It is therefore intriguing to speculate that during
the evolution of cell-to-cell communication in multicellular
organisms DEAD box RNA helicases were coopted and used
in an RNA independent manner.
5. Conclusion
XPD, LysRS, as well as DEAD box proteins are multifunc-
tional proteins, involved in a myriad of biological activities.
Analyzing them in more detail revealed several commonali-
ties. First, these enzymes donot require their enzymatic activ-
ity for every function. Second, they interact with different
protein complexes, which direct their multifunctional poten-
tial into specific biological processes. Third, modifications
like phosphorylation often regulate their interaction affinities
and thereby their activities.This (re)directs their activity into
one particular pathway (Figure 4).
We noted that there are at least three modes in which
MFPs work. For some, there is no obvious connection
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between their activity (Figure 1) other than the common
function or structure of the MFP. This could represent an
early step in the evolution of a MFP or an early phase in its
exploration by scientists. We also found cases where MFPs
promote subsequent steps in a workflow (Figure 2(a)), like
a conveyor belt or a peristaltic pump that keeps the flow at
different steps in the process. These functions can either be
performed by the same activity or by utilizing two different
activities of the MFP, for example, once the structural and
once the enzymatic function. A prerequisite for being able to
promote several different steps is that this promoting factor,
the MFP, is not limited in the cell (Figure 2). Finally, when
MFPs and factors that control their activity become limited,
a MFP may only be available for one of its functions. In
such cases the MFP acts as a molecular switch (Figure 3).
From these models it is evident that even simple quantitative
aspects such as abundance of the MFP can decide the final
output of an MFP. For instance, as shown in Figure 2(b),
as long as there is ample MFP available, it can support two
processes in the cell. However, when MFP becomes limited,
as depicted in Figure 3, then it will preferentially promote the
pathway for which it has the higher affinity.
Our analysis of MFPs presented here also revealed that
complex dynamics repeatedly plays crucial roles in regulating
the multiple functions properly (Figure 4). These alternative
interactions are often regulated by posttranslational modifi-
cations and can be accompanied by differential subcellular
localization. For the proper study of such events we need to
find out which complexes form in which compartment of a
cell and monitor the activity of the MFP in different envi-
ronments. Here lies a big challenge for the future to develop
more quantitative tools to monitor subcellular activities and
complexes. While such tools are being developed for some
applications, many more need to follow and will have to be
made suitable for living cells or even organisms.
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